Status:
UNKNOWN
Cohort Study on People Who Inject Drugs in Senegal
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Conditions:
Drug Addiction
HIV/AIDS
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of the CoDISEN cohort study is to propose a model of prevention and care for HIV and viral hepatitis adapted to the needs of people who inject drugs (PWID) in Dakar, Senegal.
Detailed Description
THE UNODC estimated the number of consumers of injectable drugs at 1,02 millions in 2012 in Africa among which 12,1 % lived with HIV. Prevalences of HIV, chronic hepatitis C and B among people who inj...
Eligibility Criteria
Inclusion
- being aged greater than or equal to 18 years or emancipated minor,
- Being or have been an injecting drug user and followed at the CEPIAD (methadone program)
- Living in the Dakar region for at least three months,
- Consenting to the study after individual information.
Exclusion
- Mental impairment making it difficult or impossible to consent to the study.
Key Trial Info
Start Date :
August 24 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT03459768
Start Date
August 24 2016
End Date
June 30 2021
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CEPIAD
Dakar, Senegal